Home » Topics » Regulatory » Patents

Patents
RSS

Noncardiotoxic anthracyclines disclosed by Gem

April 6, 1999

Roche presents new metabotropic glutamate receptor ligands in the patent literature

April 6, 1999

Novel furansulfonic acid compounds for neurodegenerative, autoimmune and inflammatory disorders

April 6, 1999

Patent issued for new Merck glucagon antagonists

April 5, 1999

Therapeutically useful PDE4 inhibitors in development at ADIR

April 5, 1999

Inhibitors of the formation of AGTs described by Alteon

April 5, 1999

Protein farnesyltransferase inhibitors emerge from Schering-Plough/Pharmacopeia collaboration

April 1, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Dopaminergic agents for anxiety, depression and Parkinson's disease disclosed by ADIR

April 1, 1999

New microtubule-stabilizing agents developed at Schering

April 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...